跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 545 条关于
“MPER”
全部
545
临床试验
449
药物
31
机构
15
资讯
50
2年前
HIV Vaccine Breakthrough: New Candidate Successfully Generates Broadly Neutralizing Antibodies
上个月
Meijer Expands Vaccine Access with New Schedule-Ahead Feature and Mobile Clinics Ahead of Flu Season
去年
Ensysce Biosciences' PF614-MPAR Demonstrates Overdose Protection in Clinical Trial
去年
Ensysce Biosciences Advances Abuse-Resistant Opioids PF614 and PF614-MPAR Towards Market
9个月前
Ensysce Biosciences Secures Extended Patent Protection for MPAR Overdose Prevention Technology Through 2042
2年前
Ensysce Biosciences Advances Novel Analgesics PF614 and PF614-MPAR Towards Phase 3 Trials
10个月前
Repare Therapeutics Agrees to $1.82 Per Share Acquisition by XenoTherapeutics
9个月前
XOMA Royalty Completes $2.035 Per Share Acquisition of Mural Oncology
10个月前
Repare Therapeutics Agrees to $1.82 Per Share Acquisition by XenoTherapeutics
2年前
FDA Gears Up for Key Approval Decisions in Q4 2024
第 1 页,共 5 页
上一页
下一页